Overview

Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07

Status:
Completed
Trial end date:
2016-11-22
Target enrollment:
Participant gender:
Summary
This is a long-term-safety roll-over extension study for a Phase II Study (Protocol CPC-001-07).
Phase:
Phase 2
Details
Lead Sponsor:
Chase Pharmaceuticals Corporation
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc